19. Received immunoglobulin or other blood products (with exception of Rho D immunoglobulin) within 90 days prior to study vaccination 20. Received an experimental agent7 within 30 days prior to the first study vaccination, or expects to receive an experimental agent8 during the 13-month study-reporting period. Including vaccine, drug, biologic, device, blood product, or medication. Other than from participation in this study.